1-10 of 10
H. Evin Gulbahce
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database

Michael Balatico, MD, Ana L. Ruano, MD, Allison S. Cleary, MD, PhD, Lesley Lomo, MD, H. Evin Gulbahce, MD, MSCI
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2024) 148 (3): 263–264.
https://doi.org/10.5858/arpa.2023-0364-LE
Published: 26 February 2024
View article titled, Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database
Open the PDF for Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database in another window
Journal Articles

Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)

Diane Wilcock, MS, Deepika Sirohi, MD, Daniel Albertson, MD, Allison S. Cleary, MD, PhD, Joshua F. Coleman, MD ...
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2023) 148 (8): 890–897.
https://doi.org/10.5858/arpa.2023-0275-OA
Published: 07 November 2023
View article titled, Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio &lt;2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)
Open the PDF for Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) in another window
Journal Articles

The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study

H. Evin Gulbahce, MD, MSCI, Erinn Downs-Kelly, DO, Kimberly A. Herget, MStat, Gregory J. Stoddard, MBA, MPH
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2021) 146 (4): 478–484.
https://doi.org/10.5858/arpa.2020-0837-OA
Published: 03 August 2021
View article titled, The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study
Open the PDF for The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer: A Population-Based Study in another window
Journal Articles

Interference of Tissue-Marking Dyes With Fluorescence In Situ Hybridization Assays

H. Evin Gulbahce, MD, Joshua F. Coleman, MD, Deepika Sirohi, MD
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2019) 143 (11): 1299.
https://doi.org/10.5858/arpa.2019-0255-LE
Published: 01 November 2019
View article titled, Interference of Tissue-Marking Dyes With Fluorescence In Situ Hybridization Assays
Open the PDF for Interference of Tissue-Marking Dyes With Fluorescence In Situ Hybridization Assays in another window
Journal Articles

RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory

Ling Hui, MD, PhD, Katherine B. Geiersbach, MD, Erinn Downs-Kelly, DO, H. Evin Gulbahce, MD
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2016) 141 (2): 274–278.
https://doi.org/10.5858/arpa.2016-0201-OA
Published: 13 December 2016
View article titled, RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory
Open the PDF for RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory in another window
Journal Articles

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer

H. Evin Gulbahce, MD;, Rachel Factor, MD;, Katherine Geiersbach, MD;, Erinn Downs-Kelly, DO
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2016) 140 (8): 741.
https://doi.org/10.5858/arpa.2016-0015-LE
Published: 01 August 2016
View article titled, HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer
Open the PDF for HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer in another window
Journal Articles

Variability of Pathologists' Utilization of p16 and Ki-67 Immunostaining in the Diagnosis of Cervical Biopsies in Routine Pathology Practice and Its Impact on the Frequencies of Cervical Intraepithelial Neoplasia Diagnoses and Cytohistologic Correlations

Charanjeet Singh, MD, J. Carlos Manivel, MD, Alexander M. Truskinovsky, MD, Kay Savik, MS, Samy Amirouche, CT(ASCP) ...
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2014) 138 (1): 76–87.
https://doi.org/10.5858/arpa.2012-0472-OA
Published: 01 January 2014
View article titled, Variability of Pathologists' Utilization of p16 and Ki-67 Immunostaining in the Diagnosis of Cervical Biopsies in Routine Pathology Practice and Its Impact on the Frequencies of Cervical Intraepithelial Neoplasia Diagnoses and Cytohistologic Correlations
Open the PDF for Variability of Pathologists' Utilization of p16 and Ki-67 Immunostaining in the Diagnosis of Cervical Biopsies in Routine Pathology Practice and Its Impact on the Frequencies of Cervical Intraepithelial Neoplasia Diagnoses and Cytohistologic Correlations in another window
Journal Articles

Prostatic Glands and Urothelial Epithelium in a Seminal Vesicle Cyst: Report of a Case and Review of Pathologic Features and Prostatic Ectopy

Deniz L. Aslan, MD, Stefan E. Pambuccian, MD, H. Evin Gulbahce, MD, Michael L. Tran, MD, J. Carlos Manivel, MD
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2006) 130 (2): 194–197.
https://doi.org/10.5858/2006-130-194-PGAUEI
Published: 01 February 2006
View article titled, Prostatic Glands and Urothelial Epithelium in a Seminal Vesicle Cyst: Report of a Case and Review of Pathologic Features and Prostatic Ectopy
Open the PDF for Prostatic Glands and Urothelial Epithelium in a Seminal Vesicle Cyst: Report of a Case and Review of Pathologic Features and Prostatic Ectopy in another window
Journal Articles

Pulmonary Complications After Bone Marrow Transplantation: An Autopsy Study From a Large Transplantation Center

Monika Roychowdhury, MD, Stefan E. Pambuccian, MD, Deniz L. Aslan, MD, Jose Jessurun, MD, Alan G. Rose, MD ...
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (2005) 129 (3): 366–371.
https://doi.org/10.5858/2005-129-366-PCABMT
Published: 01 March 2005
View article titled, Pulmonary Complications After Bone Marrow Transplantation: An Autopsy Study From a Large Transplantation Center
Open the PDF for Pulmonary Complications After Bone Marrow Transplantation: An Autopsy Study From a Large Transplantation Center in another window
Journal Articles

Metastatic Leydig Cell Tumor With Sarcomatoid Differentiation

H. Evin Gulbahce, MD, Arthur T. Lindeland, MD, William Engel, MD, Tamera J. Lillemoe, MD
Journal: Archives of Pathology & Laboratory Medicine
Arch Pathol Lab Med (1999) 123 (11): 1104–1107.
https://doi.org/10.5858/1999-123-1104-MLCTWS
Published: 01 November 1999
View article titled, Metastatic Leydig Cell Tumor With Sarcomatoid Differentiation
Open the PDF for Metastatic Leydig Cell Tumor With Sarcomatoid Differentiation in another window